日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 91视频a| 青青操视频在线观看 | 经典三级av在线 | 少妇久久久久久久久久 | 国产午夜麻豆影院在线观看 | 色婷婷激情网 | 黄色理论视频 | 亚洲影院在线 | 嫩操影院| 少妇99| 亚欧成人精品一区二区 | 欧美脚交视频 | 视频一区二区三区在线观看 | 在线免费观看黄色小视频 | 亚洲一区欧美二区 | 色欧美片视频在线观看 | 国产超级av | 男人天堂视频网 | 麻豆国产91在线播放 | 国产成人精品视频在线观看 | 毛片视频免费观看 | 欧美专区在线视频 | 日本欧美在线视频 | 福利视频在线看 | 久久com| 午夜影院黄色 | 四虎884aa成人精品 | 欧美性生交 | 成年人在线视频观看 | 四虎影视在线播放 | 中文字幕在线免费观看视频 | 欧美性x x x 久久99精品久久久久久噜噜 | 朝桐光一区二区三区 | 欧美精品午夜 | 欧美日韩视频在线 | 久久久免费网站 | 日本一区免费观看 | 亚欧洲精品在线视频免费观看 | 91最新国产| 新av在线 | 天天色综合色 |